Related Experiment Video
Updated: Jun 20, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
A systematic review of the methodological quality of randomised trials in IBD surgery
Kelsey Aimar1, Aditya Gaur2, Michael Peirson3
1Belfast Health and Social Care Trust, Belfast, UK.
Aims:
This systematic review aimed to evaluate the design, statistical robustness and real-world applicability of randomised controlled trials in IBD surgery.
Methods:
A systematic review of RCTs involving adult patients with IBD undergoing surgical interventions was conducted. Databases and registries were searched from 2005 to 2025. Dual screening and extraction were performed. Trials were appraised using RoB-2, PRECIS-2 and fragility index. The study was registered with PROSPERO (CRD420251058758).
Results:
From 5803 abstracts, 18 published RCTs and 26 registered but unpublished trials were identified. Published RCTs had a median planned sample size of 102 participants (IQR 80-143) and recruited a median of 89 (IQR 55-114), with frequent under-recruitment (7/18, 39%) and early termination (5/18, 28%). Methodological appraisal revealed that most studies (12/18, 67%) had some concern for bias on RoB-2 assessment. PRECIS-2 evaluation showed a tendency towards pragmatic designs. The median fragility index was 3 (IQR 1-6). Of registered, unpublished trials, median planned sample size was 155 (IQR 93-196), with the largest study having a planned enrolment of 550 participants.
Conclusions:
Surgical RCTs in IBD face challenges across design and delivery, such as modest sample sizes, under-recruitment and statistical fragility. The findings from this review highlight the importance of larger, multicentre and collaborative trials to strengthen the evidence base in IBD surgery.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction